Pyruvate and glucose were also found to be increased in CSF and plasma of ALS patients (Table S1), potentially reflecting a dysregulation of glycolytic metabolism as observed in SOD1-G93A motor neurons (187), and in some ALS cases (188, 189). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.